Advancing Work in the Fight Against Pancreatic Cancer

The WFPCRF cannot bring back my husband, but it can raise money to support pancreatic research here in Pittsburgh, a world leader in the field. Our primary focus is early detection and genetics, our foundation is dedicated to funding critically important pancreatic cancer research at the University of Pittsburgh where cutting-edge and vital research is being done. Keeping our donations local is something we pride ourselves on, and we hope that this can be a source of pride for you as well.

Dr Brand's information

Randall Brand, MD, is a gastroenterologist and is certified in gastroenterology by the American Board of Internal Medicine. He is a Professor of Medicine at the University of Pittsburgh School of Medicine and is the academic director for the GI Division at UPMC Shadyside Hospital. Dr. Brand also directs the University of Pittsburgh Medical Center’s GI Malignancy Early Detection, Diagnosis, and Prevention Program and leads UPMC’s Hereditary GI Tumor Clinic. He received his medical degree and completed his residency at the University of Michigan Medical Center, followed by his fellowship at the University of California, San Francisco.

Dr. Brand’s clinical interests include the early detection of pancreatic cancer, evaluating and caring for family members from pancreatic cancer-prone families, hereditary GI cancers, and the evaluation and management of pancreatic cystic lesions and acute and chronic pancreatitis. He has been honored as a fellow of both the American Gastroenterological Association and the American College of Gastroenterology. Dr. Brand is also a member of the American Pancreatic Association and has served as the President of the Collaborative Groups of the Americas on Inherited Gastrointestinal Cancers and the Collaborative Alliance for Pancreatic Education and Research. He is a principal investigator in the Early Detection Research Network, Pancreatic Cancer Detection Consortium, Chronic Pancreatitis, Diabetes and Pancreatic Cancer Consortium, and participates in multiple NCI-, NIH- and DoD-funded research projects focused on the early detection of pancreatic cancer. His work is aimed at finding new tests to find a pancreatic cancer when it is small and asymptomatic, and the identification of high-risk individuals who would benefit from pancreatic cancer screening.